Adamas Pharmaceuticals, Inc. ADMS
$ 8.22
0.0%
Adamas Pharmaceuticals, Inc. Balance Sheet 2011-2024 | ADMS
Annual Balance Sheet Adamas Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
58.3 M | 61.9 M | 62.5 M | 11.3 M | -23.7 M | -33.1 M | -61.4 M | -85.6 M | -59 M | - |
Long Term Debt |
126 M | 126 M | 117 M | 103 M | - | - | - | - | - | - |
Total Non Current Liabilities |
135 M | 136 M | 121 M | 103 M | 547 K | 749 K | 1.57 M | 12 K | 20.9 M | - |
Total Current Liabilities |
34.9 M | 26.9 M | 24.3 M | 16.6 M | 9.74 M | 11.8 M | 12.5 M | 4.22 M | 38.5 M | - |
Total Liabilities |
170 M | 163 M | 145 M | 120 M | 10.3 M | 12.6 M | 14.1 M | 4.23 M | 59.3 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | 29.6 M | - |
Retained Earnings |
-505 M | -448 M | -343 M | -212 M | -122 M | -62.2 M | -10.3 M | -20.6 M | -71.5 M | - |
Total Assets |
120 M | 162 M | 235 M | 186 M | 142 M | 129 M | 161 M | 86.2 M | 64.3 M | - |
All numbers in USD currency